Obinutuzumab Intravenous and Sinequan (Doxepin Oral Concentrate)
Determining the interaction of Obinutuzumab Intravenous and Sinequan (Doxepin Oral Concentrate) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: obinutuzumab
Brand name: Gazyva
Synonyms: Obinutuzumab
Generic Name: doxepin
Brand name: Sinequan, Sinequan, Silenor
Synonyms: Sinequan Capsules, Sinequan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Obinutuzumab Intravenous-Sinex Long-Acting
- Obinutuzumab Intravenous-Sinex Nasal Spray
- Obinutuzumab Intravenous-Singulair
- Obinutuzumab Intravenous-Singulair (Montelukast Chewable Tablets)
- Obinutuzumab Intravenous-Singulair (Montelukast Oral Granules)
- Obinutuzumab Intravenous-Singulair (Montelukast Tablets)
- Sinequan (Doxepin Oral Concentrate)-Obizur
- Sinequan (Doxepin Oral Concentrate)-Obizur Intravenous
- Sinequan (Doxepin Oral Concentrate)-Obredon
- Sinequan (Doxepin Oral Concentrate)-Ocaliva
- Sinequan (Doxepin Oral Concentrate)-Occlucort
- Sinequan (Doxepin Oral Concentrate)-Occlusal-HP Topical